User login
Metabolic syndrome was significantly more prevalent in patients with bipolar disorder than in those with major depressive disorder or in controls, Barbora Silarova, Ph.D., and her coauthors reported.
In a study of 2,431 patients the investigators found that those with bipolar disorder had a significantly higher prevalence of metabolic syndrome, compared with patients with major depressive disorder and nonpsychiatric controls (28.4% vs. 20.2% and 16.5%, respectively; P < .001). This difference was consistent when adjusted for sociodemographic and lifestyle factors, Dr. Silarova and her colleagues said in the paper.
“Clinically, it might be relevant to apply individualized treatment for [bipolar disorder] patients that also includes assessment of metabolic risk factors, psychoeducation, weight loss intervention, and improvement of health-related behaviors,” the authors said.
Read the full article in the Journal of Psychosomatic Research here.
Metabolic syndrome was significantly more prevalent in patients with bipolar disorder than in those with major depressive disorder or in controls, Barbora Silarova, Ph.D., and her coauthors reported.
In a study of 2,431 patients the investigators found that those with bipolar disorder had a significantly higher prevalence of metabolic syndrome, compared with patients with major depressive disorder and nonpsychiatric controls (28.4% vs. 20.2% and 16.5%, respectively; P < .001). This difference was consistent when adjusted for sociodemographic and lifestyle factors, Dr. Silarova and her colleagues said in the paper.
“Clinically, it might be relevant to apply individualized treatment for [bipolar disorder] patients that also includes assessment of metabolic risk factors, psychoeducation, weight loss intervention, and improvement of health-related behaviors,” the authors said.
Read the full article in the Journal of Psychosomatic Research here.
Metabolic syndrome was significantly more prevalent in patients with bipolar disorder than in those with major depressive disorder or in controls, Barbora Silarova, Ph.D., and her coauthors reported.
In a study of 2,431 patients the investigators found that those with bipolar disorder had a significantly higher prevalence of metabolic syndrome, compared with patients with major depressive disorder and nonpsychiatric controls (28.4% vs. 20.2% and 16.5%, respectively; P < .001). This difference was consistent when adjusted for sociodemographic and lifestyle factors, Dr. Silarova and her colleagues said in the paper.
“Clinically, it might be relevant to apply individualized treatment for [bipolar disorder] patients that also includes assessment of metabolic risk factors, psychoeducation, weight loss intervention, and improvement of health-related behaviors,” the authors said.
Read the full article in the Journal of Psychosomatic Research here.